Posted by This Special Issue in Molecules aims to implement the information regarding the use of cyclodextrins and their molecular complexes to evaluate their potential role in multiple applications.
Editors:
Prof. Dr. Thomas Mavromoustakos
Department of Chemistry, National & Kapodistrian University of Athens, Athens, Greece
Interests: hypertension; structure elucidation; nuclear magnetic resonance; spectroscopy; NMR spectroscopy; medicinal and pharmaceutical chemistry; molecular modeling; Raman spectroscopy; DSC; NMR structure elucidation
Dr. Andreas Tzakos
Department of Chemistry, University of Ioannina, Ioannina, Greece
Interests: development of tumor-homing and tumor-responsive drug delivery vehicles as theranostics; drug formulations and prodrugs; development of imaging agents for visualizing and charting cellular compartments; pharmacokinetics (LC-MS, HPLC-based) and bioactivity evaluation; design and development of cancer diagnostics and theranostics; development of tumor-homing probes equipped with multimodal imaging agents (for MRI, in vivo near-infrared I & II optical imaging, and SPECT/PET probes)
Prof. Dr. Georgia N. Valsami
Department of Pharmacy, National & Kapodistrian University of Athens, Athens, Greece
Interests: drug-protein binding; drug-cyclodextrins interaction, characterization and effect on drug solubility/dissolution/absorption; Development and in vitro-in vivo evaluation of novel dosage forms with optimized absorption (GI/nasal/pulmonary); PK/PD studies and dosage individualization
Submissions before 31 March 2022: 400 CHF discount.
Website: https://www.mdpi.com/journal/molecules/special_issues/drug_cyclodextrin